Abstract
Anticoagulant rodenticides, a key tool in pest control since the 1940s, have undergone significant evolution to overcome resistance and improve efficacy. However, resistance in rodent populations led to the development of second-generation anticoagulants such as Brodifacoum and Difenacoum, which are more potent but pose increased risks to non-target species, including humans. This case report describes the management of a 16-year-old Iranian male who deliberately ingested a super warfarin rodenticide, resulting in severe coagulopathy and delayed clinical presentation. Despite the initial absence of overt symptoms, the patient’s condition required immediate intervention with intravenous vitamin K and blood products, demonstrating the complexity of diagnosing and managing rodenticide poisoning. Recovery was achieved with comprehensive medical and psychological interventions, demonstrating the need for high clinical suspicion and prompt treatment in similar cases. This report highlights the ongoing public health challenges posed by highly potent rodenticides and the critical need for awareness and preparedness among healthcare providers to effectively manage such emergencies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
